Nubain is a medicine used to relieve pain. It works by blocking pain signals in the body. It's a type of opioid pain reliever.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Nalbuphine is a prescription opioid pain medicine given by injection. It is used for pain severe enough to need an opioid when other treatments are not enough, and it is mainly given in hospitals, clinics and around surgery: before and after an operation, as part of anesthesia, and sometimes for pain relief during labor. It was once sold under the brand name Nubain, which is no longer marketed in the US; it is now available as a generic injection. Clinicians also use nalbuphine, outside its formal approval, to prevent or relieve the itching that commonly follows morphine or similar opioids given through a spinal or epidural injection. Its US label covers adults; safety and effectiveness in children and teenagers have not been established.
Opioids relieve pain by acting on opioid receptors, docking sites on nerve cells in the brain and spinal cord. Most familiar opioids, such as morphine and oxycodone, switch on the mu receptor, which brings strong pain relief but also drives much of the breathing slowdown, itching and euphoria opioids are known for. Nalbuphine works differently: it switches on a second type, the kappa receptor, to relieve pain while partly blocking the mu receptor. That is why it is called a mixed agonist-antagonist. Two practical consequences follow. Up to about 30 mg, nalbuphine relieves pain about as well as the same amount of morphine, and beyond that point extra doses do not keep deepening its effect on breathing when it is used alone, a so-called ceiling effect. Its mu-blocking action also explains why it can ease opioid-related itching, and why it can cause withdrawal in someone who depends on other opioids.
Nalbuphine comes only as an injection, given under the skin, into a muscle or into a vein; there is no tablet or nasal spray form in the US. A nurse or clinician usually gives it. Relief starts within 2 to 3 minutes when injected into a vein and within about 15 minutes after an injection into a muscle or under the skin, and it typically lasts 3 to 6 hours, so doses may be repeated every few hours as needed. The care team chooses the dose based on pain severity, body size, age, overall health and other medicines, and uses the lowest dose that controls the pain. Larger doses are used during anesthesia, where breathing is closely monitored. Older adults and people with reduced kidney function are often started lower because they can be more sensitive to it. Anyone sent home with nalbuphine should use it exactly as directed and not raise the dose on their own.
Sleepiness is by far the most common side effect; about a third of people in clinical studies felt sedated. Others include sweating or a clammy feeling, nausea or vomiting, dizziness, dry mouth and headache. Some people feel lightheaded or faint when they stand up because of a drop in blood pressure, so getting up slowly helps. Less often, nalbuphine causes anxiety, confusion, unusual dreams or a sense of unreality. Like all opioids, nalbuphine carries a boxed warning, the most serious warning the US Food and Drug Administration (FDA) puts on a label, for slowed or shallow breathing that can be life-threatening, most likely after the first dose or a dose increase. In the hospital, staff watch for this and can reverse it with naloxone. Outside the hospital, if someone who has had nalbuphine is breathing very slowly or shallowly, cannot be woken or collapses, give naloxone if it is available and call 911. Serious allergic reactions are rare but possible; hives with trouble breathing or swallowing, or swelling of the face, lips, tongue or throat, also need emergency care.
The most dangerous combination is nalbuphine with other drugs that slow the brain and breathing. Benzodiazepines (sedatives such as alprazolam or lorazepam), sleeping pills, alcohol, other opioids, some muscle relaxants and the nerve-pain medicines gabapentin and pregabalin can together cause deep sedation, stopped breathing, coma or death. This is part of nalbuphine's boxed warning, so the care team needs to know about every sedating medicine and about alcohol use. Because nalbuphine partly blocks the mu receptor, it can weaken the pain relief of morphine, oxycodone, fentanyl and similar opioids, and it can trigger sudden withdrawal in people who take opioids regularly, including for opioid use disorder. It is not recommended with monoamine oxidase (MAO) inhibitors (an older class of antidepressants, plus the antibiotic linezolid) or within 14 days of stopping one. With other drugs that raise serotonin, such as many antidepressants and triptan migraine medicines, it can rarely contribute to serotonin syndrome; agitation, fever, shaking, muscle stiffness or twitching after starting it should be reported right away. Nalbuphine, like other opioids, carries a risk of addiction, misuse and overdose, which is higher for people with a past substance use disorder. It is not used in people with seriously slowed breathing, an acute or severe asthma attack without close monitoring, a known or suspected bowel blockage, or an allergy to nalbuphine, and it needs extra care with lung disease, head injury, seizures, or liver, kidney or gallbladder disease. During labor it crosses quickly to the baby and can slow the baby's heart rate or cause breathing problems at birth, so it is used only when clearly needed, with fetal and newborn monitoring. Long-term use late in pregnancy can lead to withdrawal in the newborn.
For most people, nalbuphine is a short-term treatment given during a hospital stay, a procedure or labor. Pain relief comes quickly, and it is usually combined with or followed by other pain medicines as recovery goes on. Studies comparing it with morphine after surgery found similar pain relief, with less itching, nausea and vomiting, though these studies were small. People who already take strong opioids may find it less effective, which is one reason the care team asks about current medicines. Nalbuphine can impair alertness and coordination, so do not drive or operate machinery until its effects have fully worn off. After regular use for more than a few days, the body can become dependent on it, and stopping suddenly can cause withdrawal symptoms such as restlessness, sweating, a runny nose, aches and stomach cramps; in that case the dose is reduced gradually.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Nubain (Nalbuphine), what you've noticed, or ask the community a question.